GlaxoSmithKline plc (GSK) Ordinary 25p
Share news, reports & tips
20 November 2020 08:34
(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied...
9 November 2020 08:12
(Sharecast News) - GlaxoSmithKline announced on Monday that the independent data safety monitoring board of ViiV Healthcare had recommended the early unblinding of the HIV Prevention Trials Network (HPTN)...
28 October 2020 12:03
(Sharecast News) - GlaxoSmithKline said on Wednesday that it's on track to deliver full-year adjusted earnings per share at the lower end of its guidance range as the company's vaccines business...
28 October 2020 07:15
(Sharecast News) - Pharmaceutical companies GlaxoSmithKline and Sanofi said they had agreed to make 200m doses of their potential Covid-19 vaccine to a worldwide pooled facility.
27 October 2020 16:43
(Sharecast News) - The economic and corporate news-flow is light on Wednesday, although investors will continue to keep an eye on the election polls ahead of the 3 November presidential and Congressional...
21 October 2020 14:19
(Sharecast News) - Learning Technologies Group: Canaccord upgrades to buy with a target price of 150p.
8 October 2020 11:42
(Sharecast News) - US drug giant Eli Lilly's monoclonal antibody treatment is effective in reducing levels of the novel coronavirus in patients and appears to be able to keep them from having to go go...
1 October 2020 09:04
(Sharecast News) - Moderna's Covid-19 vaccine candidate will not be ready by the 3 November presidential elections in the US, but it could be by the end of that month.
28 September 2020 13:30
(Sharecast News) - Inovio's phase 2/3 trial of its Covid-19 vaccine candidate was put on partial hold by the US Food and Drug Administration, sending the shares crashing.
18 September 2020 11:01
(Sharecast News) - The European Union agreed an advance purchase agreement with Sanofi and GlaxoSmithKline for the companies' potential Covid-19 vaccine.
9 September 2020 13:25
(Sharecast News) - Analysts at Jefferies reiterated their 'hold' recommendation for shares of AstraZeneca following the pharma giant's decision to press the pause button on its phase three...
9 September 2020 12:52
(Sharecast News) - One of the Covid-19 vaccine candidates being developed by German outfit BioNTech and Pfizer succeeded in pre-clinical challenge trials.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.